NCT00142948View on ClinicalTrials.gov

Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts

PHASE2CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Heroin Dependence
Interventions
DRUG

Naltrexone

naltrexone

DRUG

Placebo

placebo

Trial Locations (1)

Unknown

Saint Petersburg Pavlov State Medical University, Saint Petersburg

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Baylor College of Medicine

OTHER

NCT00142948 - Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts | Biotech Hunter | Biotech Hunter